학술논문
Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16
Document Type
Article
Author
Source
In ESMO Open October 2023 8(5)
Subject
Language
ISSN
2059-7029